alexa Treatment of Nonsense Mutations Using Stop Codon Read-t
ISSN: 1747-0862

Journal of Molecular and Genetic Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Treatment of Nonsense Mutations Using Stop Codon Read-through Therapeutics and Creation of Animal Models Using CRISPR-Cas9

Kelly A. Turner1,2,3 and Francis YM Choy1*

1Centre for Biomedical Research, Department of Biology, University of Victoria, 3020, Station CSC, Victoria, BC, V8W 3N5, Canada

2Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 1L3

3Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3

Corresponding Author:
Francis Y.M. Choy
Centre for Biomedical Research
Department of Biology, University of Victoria
3020, Station CSC, Victoria, BC
V8W 3N5, Canada
Tel: 1-250-721-7107
Fax: 1-250-721-7120
E-mail: [email protected]

Received Date: May 23, 2015 Accepted Date: June 27, 2015 Published Date: July 04, 2015

Citation:Turner KA, Choy FYM (2015) Treatment of Nonsense Mutations Using Stop Codon Read-through Therapeutics and Creation of Animal Models Using CRISPR-Cas9. J Mol Genet Med 9:172. doi:10.4172/1747-0862.1000172

Copyright: ©2015 Turner KA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Premature termination codons result when a mutation within a protein coding sequence causes an amino acidencoding sense codon to be interpreted as a stop codon. Often, this results in truncation and destruction of the mRNA transcript or a non-functional protein. Nonsense mutations account for approximately 11% of all described mutations that contribute to disease. A number of therapeutics, including suppressor tRNAs, gentamicin, and PTC124, have been developed that purport to promote the “read-through” of these premature termination codons so that they are interpreted as sense codons. This, theoretically, would reconstitute the full-length transcript and restore protein/enzyme function and ameliorate disease symptoms. Currently, the implementation of such therapeutics in a clinical setting has been slow due to factors such as toxicity and inefficiency. We will discuss these hurdles as well as the difficulties associated with determination of the required protein/enzyme level to reduce symptoms as well as breakthroughs in genome editing to create nonsense mutation animal models using the clustered regularly interspersed short palindromic repeats-CRISPR-associated protein 9 system.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version